Cargando…

Clinical implications of APEX1 and Jagged1 as chemoresistance factors in biliary tract cancer

PURPOSE: Biliary cancer is a highly malignant neoplasm with poor prognosis and most patients need to undergo palliative chemotherapy, however major clinical problem associated with the use of chemotherapy is chemoresistance. So far, we aimed at investigating clinical implications of apurinic/apyrimi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kim, Hong-Beum, Cho, Won Jin, Choi, Nam Gyu, Kim, Sung-Soo, Park, Jun Hee, Lee, Hee-Jeong, Park, Sang Gon
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Korean Surgical Society 2017
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5234431/ https://www.ncbi.nlm.nih.gov/pubmed/28090501 http://dx.doi.org/10.4174/astr.2017.92.1.15

Ejemplares similares

Jagged-2 (JAG2) enhances tumorigenicity and chemoresistance of colorectal cancer cells
por: Vaish, Vivek, et al.
Publicado: (2017)

Therapeutic implication of HER2 in advanced biliary tract cancer
por: Nam, Ah-Rong, et al.
Publicado: (2016)

BRCA/Fanconi anemia pathway implicates chemoresistance to gemcitabine in biliary tract cancer
por: Nakashima, Shinsuke, et al.
Publicado: (2015)

Jab1 Silencing Inhibits Proliferation and Sensitizes to Cisplatin in Biliary Tract Cancer
por: Nam, Ah-Rong, et al.
Publicado: (2019)

Jagged1 intracellular domain modulates steroidogenesis in testicular Leydig cells
por: Kumar, Sudeep, et al.
Publicado: (2020)

The role of Jagged1 as a dynamic switch of cancer cell plasticity in PDAC assembloids
por: Choi, Jae-Il, et al.
Publicado: (2022)

Hypertension and Biliary Ductopenia in a Patient with Duplication of Exon 6 of the JAG1 Gene
por: Uberos, J., et al.
Publicado: (2012)

Angioleiomyoma in the Orbital Apex: A Case Report
por: Lee, Boeun, et al.
Publicado: (2019)

Inhibition of WEE1 Potentiates Sensitivity to PARP Inhibitor in Biliary Tract Cancer
por: Seo, Hye-Rim, et al.
Publicado: (2022)

Extremely rare case of successful treatment of metastatic ovarian undifferentiated carcinoma with high-dose combination cytotoxic chemotherapy: A case report
por: Kim, Hong Beum, et al.
Publicado: (2020)

The Role of ROR1 in Chemoresistance and EMT in Endometrial Cancer Cells
por: Lee, Kyung-Jun, et al.
Publicado: (2023)

APEX1 predicts poor prognosis of gallbladder cancer and affects biological properties of CD133(+) GBC-SD cells via upregulating Jagged1
por: Wu, Zhengchun, et al.
Publicado: (2023)

Solitary Extramedullary Plasmacytoma of the Apex of Arytenoid: Endoscopic, CT, and Pathologic Findings
por: Kim, Kyung Soo, et al.
Publicado: (2012)

Bronchobiliary fistula after ramucirumab treatment for advanced gastric cancer: A case report
por: Kim, Hong-Beum, et al.
Publicado: (2019)

Arterioportal shunt incidental to treatment with oxaliplatin that mimics recurrent gastric cancer
por: Kim, Hong-Beum, et al.
Publicado: (2017)

The Clinical Impact of c-MET Over-Expression in Advanced Biliary Tract Cancer (BTC)
por: Heo, Mi Hwa, et al.
Publicado: (2017)

Annexin A2 Stabilizes Oncogenic JAG1 Intracellular Domain by Inhibiting Proteasomal Degradation in Glioblastoma Cells
por: Ham, Seok Won, et al.
Publicado: (2023)

APEX1 Polymorphism and Mercaptopurine-Related Early Onset Neutropenia in Pediatric Acute Lymphoblastic Leukemia
por: Kim, Hyery, et al.
Publicado: (2018)

Jagged-1/Notch Pathway and Key Transient Markers Involved in Biliary Fibrosis during Opisthorchis felineus Infection
por: Kovner, Anna, et al.
Publicado: (2022)

Association analysis and functional follow-up identified common variants of JAG1 accounting for risk to biliary atresia
por: Bai, Mei-Rong, et al.
Publicado: (2023)

Somatic Mutations from Whole Exome Sequencing Analysis of the Patients with Biliary Tract Cancer
por: Yoon, Kyong-Ah, et al.
Publicado: (2018)

The Expression of Programmed Death-Ligand 1 on Immune Cells Is Related to a Better Prognosis in Biliary Tract Cancer
por: Kwon, Sung Chan, et al.
Publicado: (2023)

Inhibition of ATR Increases the Sensitivity to WEE1 Inhibitor in Biliary Tract Cancer
por: Nam, Ah-Rong, et al.
Publicado: (2020)

RRM1 Expression as a Prognostic Biomarker for Unresectable or Recurrent Biliary Tract Cancer Treated with Gemcitabine plus Cisplatin
por: Chun, Jung Won, et al.
Publicado: (2021)

Soluble programmed death-ligand 1 (sPDL1) and neutrophil-to-lymphocyte ratio (NLR) predicts survival in advanced biliary tract cancer patients treated with palliative chemotherapy
por: Ha, Hyerim, et al.
Publicado: (2016)

NOTCH ligands JAG1 and JAG2 as critical pro-survival factors in childhood medulloblastoma
por: Fiaschetti, Giulio, et al.
Publicado: (2014)

Assemblies of JAG1 and JAG2 determine tracheobronchial cell fate in mucosecretory lung disease
por: Reynolds, Susan D., et al.
Publicado: (2022)

Predictive Factors of Biliary Tract Cancer in Anomalous Union of the Pancreaticobiliary Duct
por: Park, Jin-Seok, et al.
Publicado: (2016)

Diagnostic Role of Bile Pigment Components in Biliary Tract Cancer
por: Ahn, Keun Soo, et al.
Publicado: (2023)

Identification of potential biomarkers for diagnosis of pancreatic and biliary tract cancers by sequencing of serum microRNAs
por: Kim, Kwondo, et al.
Publicado: (2019)

Bile Acid Analysis in Biliary Tract Cancer
por: Park, Jeong Youp, et al.
Publicado: (2006)

Epigenetic silencing of microRNA-199b-5p is associated with acquired chemoresistance via activation of JAG1-Notch1 signaling in ovarian cancer
por: Liu, Michelle X., et al.
Publicado: (2013)

Therapeutic Targeting of the DNA Damage Response Using an ATR Inhibitor in Biliary Tract Cancer
por: Nam, Ah-Rong, et al.
Publicado: (2019)

HER2 Aberrations as a Novel Marker in Advanced Biliary Tract Cancer
por: Kim, Hongsik, et al.
Publicado: (2022)

APEX1 Expression as a Potential Diagnostic Biomarker of Clear Cell Renal Cell Carcinoma and Hepatobiliary Carcinomas
por: Kim, Ji-Myung, et al.
Publicado: (2019)

Jagged1 Instructs Macrophage Differentiation in Leprosy
por: Kibbie, Jon, et al.
Publicado: (2016)

Biliary Granular Cell Tumor
por: Jung, Changwon, et al.
Publicado: (2015)

Oncogenic KRAS mutation confers chemoresistance by upregulating SIRT1 in non-small cell lung cancer
por: Shin, Dong Hoon, et al.
Publicado: (2023)

A Histone Deacetylase Inhibitor Suppresses Epithelial-Mesenchymal Transition and Attenuates Chemoresistance in Biliary Tract Cancer
por: Sakamoto, Takuya, et al.
Publicado: (2016)

CRISPR/Cpf1-mediated DNA-free plant genome editing
por: Kim, Hyeran, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_llhlvevte2e5d8c4ffa30aq613